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Introduction
Lung cancer is the most common cause of cancer-related deaths worldwide. (1) During 2014 approximately 46,400 individuals in the United Kingdom (UK) were diagnosed with lung cancer. (2) Despite the incidence of lung cancer decreasing(3), mortality rates remain high, with 1-year survival rates ranging from 71% when diagnosed at stage 1 to 16% at stage 4. (4) The National Lung Screening Trial (NLST), showed serial computed tomography (CT) scanning was associated with a 20% reduction in lung cancer mortality. (5) However, screening has potential harms, such as radiation exposure, the detection of non-clinically relevant findings, over-diagnosis and psychosocial harms. (6) (7) (8) (9) (10) (11) It is therefore important to ensure acceptability to the population being screened (12) , and that overall benefits outweigh the harms. (13) Assessments of the psychosocial impact of lung cancer screening are limited to studies using CT scanning. The NLST, Pittsburgh Lung Screening Study, and the UK Lung Cancer Screening (UKLS) Trial found increased anxiety in those with true positive screening results compared to those with negative results. The UKLS also found significantly higher cancer worry scale scores 2 weeks after receiving CT scan results in those referred for a repeat CT scan compared to those with negative results. However, absolute differences were small and not thought to be clinically important. (14) (15) (16) (17) Additionally, the Dutch-Belgian Randomized Lung Cancer Screening Trial (NELSON trial) and the Pittsburgh Lung Screening Study found increased lung cancer specific distress in those with an indeterminate result, which diminished over time. (16, 18, 19) As screening with CT scanning becomes more widespread, more people will be found to have incidental findings, such as pulmonary nodules. Pulmonary nodules are widely defined as round lesions within the lung, less than 3cm in diameter and surrounded by normal lung tissue. (20, 21) The NLST reported an incidence of pulmonary nodules of 25.9% in participants with a pack year history of at least 30 years. (5) Several studies used psychological measures to assess the negative impact of a diagnosis of pulmonary nodules (22) (23) (24) (25) , finding increased emotional distress (22, 23) , frustration and fear (25) amongst those with nodules. Additionally, French individuals diagnosed with pulmonary nodules reported lower health-related quality of life (HRQoL) (measured using the SF-36) compared to the French general population. (24) Our study assesses short and medium-term psychological responses amongst a sample of participants, with or without pulmonary nodule(s) identified on their first CT scan, within the Early Cancer Detection Test-Lung Cancer Scotland Study (ECLS Study). (26) This is a randomised controlled trial assessing the effectiveness of a blood test for lung cancer screening, measuring autoantibodies against seven antigens (Early CDT®-Lung test). (26, 27) A positive Early CDT®-Lung test is associated with a significantly increased risk of malignancy in the presence of pulmonary nodules 4-20mm in diameter (28) , and the consequent potential for adverse psychological effects. This study is therefore timely in assessing psychological impacts of this test and subsequent CT scanning.
Methods
This paper presents data on a sub-sample of participants in the ECLS study. Current or ex-smokers aged 50-75 years, with at least 20 pack-years, or fewer pack-years with a first-degree relative with lung cancer from Greater Glasgow and Clyde or Tayside, were randomised 1:1 to an Early CDT®-Lung test group or a non-screened control group. All trial participants were asked to complete a baseline questionnaire preceding awareness of group allocation. Those with positive Early CDT®-Lung tests were invited for a chest x-ray, followed by a CT scan, and then 6-monthly CT scans for 2 years. Prior to these, they were given information explaining the investigations and the possibility of finding a pulmonary nodule on their CT scan. Individuals were informed of their CT scan result in writing.
Participants who had previously consented to be contacted and those with a positive Early CDT®-Lung test were invited to participate in this nested psychological outcomes study. Those agreeing completed additional questionnaires at 1, 3, 6, 12, 18 and 24 months collecting data on psychological and behavioural outcomes. Participants were sent a £5 gift voucher for each questionnaire completed. Postal and telephone reminders were used for non-responders. No further questionnaires were sent to participants who were non-responsive to two consecutive questionnaires. On completing the 1-month questionnaire, all participants would have been aware that their Early CDT®-Lung test was positive, but 58% of participants had not yet had their CT scan, 18% had been scanned within the last 7 days, 37% within the last 14 days and 8% more than 14 days previously. Consequently, at 1-month follow-up most participants will not have known their CT scan results. The analyses presented in this paper are therefore confined to the psychological outcomes of Early CDT®-positive group participants who completed baseline and at least one follow-up questionnaire at 3 or 6 months. Participants were categorised into the nodule group if pulmonary nodule(s) ≤ 8mm in diameter were present on their first CT scan and into the normal CT group if they were absent (normal CT group participants may have had previously known stable pathology). Study ineligibility criteria can be found in Figure 1 .
Data collection
Baseline information was collected at trial recruitment, between December 2013 and April 2015 and included age, gender, smoking history, ethnic group, marital status, postcode, age at leaving full time education, employment status, family history of lung cancer (first-degree relative) and antidepressant medication use.
Psychological measures included the positive and negative affect schedule (PANAS) (29) , lung cancer worry scale (LCWS) (30) , health anxiety subscale (HAS) of the health orientation scale (31) , the impact of events scale (IES) (32) , the revised illness perception questionnaire-adapted for lung cancer (IPQ-R)(33), and lung cancer risk perception. The time points at which these were collected, descriptions and internal consistency of measures are shown in Supplementary Table 1 . Linearity of continuous covariates was checked by adding higher order terms to models. Differences in outcomes over time between the normal and CT and nodule groups were assessed by adding a group by time interaction and using likelihood ratio tests with p<0.01 taken as significant.
Analysis
Between-group differences at each time point were estimated from these models. Model assumptions were checked by plotting residual values and by excluding observations with large residual values (<-3, >3). Where residuals were not normally distributed or variance was not constant, continuous outcome measures were loge transformed (adding 1 to the IES-I and IES-A scores before transformation as some participants scored zero) and model assumptions were re-checked. Where loge transformed models met assumptions better, we present findings on the original scale and the loge transformed scale for ease of interpretation. We were unable to find a single standardised method for handling missing data for the psychological measures. Single missing values were therefore replaced with the mean or subscale score for the participant for PANAS, HAS, LCWS Impact Score and IES. When more than one value was missing the scale score was considered to be missing.
Results
Three hundred and thirty eight Early CDT®-Lung test-positive ECLS trial participants took part in the psychological outcomes study, 269 (174 in the normal CT group and 95 in the nodule group) of whom were eligible to be included in the analyses presented in this paper ( Figure 1 ). Response rates to follow-up questionnaires were high. The analysis included 95% at 3 months and 94% at 6 months.
All participants were aware of their CT scan result on completing the 3-month questionnaire. Table 1 shows baseline demographic characteristics by nodule status. There were no statistically significant differences between the nodule and normal CT groups. Psychological measures at baseline are shown in Table 2 . The only statistically significant difference was that nodule group participants had significantly higher (P=0.04) positive affect PANAS scores than normal CT group participants (median (IQR) 37.4 (27, 41.6) vs. 32 (26.7, 39) ).
Baseline demographic and psychological measures

Psychological measures at 3 and 6 months follow-up
Psychological measure scores at 3 and 6 months are shown in Table 3 and Table 4 shows adjusted differences between means and odds ratios comparing the nodule to the normal CT group at 3 and 6 months. The nodule group had statistically significantly fewer avoidance symptoms compared to the normal CT group at 3 months (difference between means in impact of events scale avoidance (IES-A) score -1.99, 95%CI -4.18, 0.21) than at 6 months (difference between means in IES-A score 0.88, 95%CI -1.32, 3.08; P-value for change over time=0.003). However, the differences in means between the nodule and normal CT groups were small at both time points. Table 5 shows differences between the means of loge transformed data for outcomes where model assumptions were better met using transformed data. Findings were similar to those using data on the original scale with lower IES-A scores in the nodule than the normal CT group at 3 months (difference in loge transformed means -0.34 (-0.65, -0.04) than at 6 months (difference in loge transformed means -0.06 (-0.36, 0.24)) but the change over time did not reach statistical significance (P=0.04). No other statistically significant differences between means or odds ratios were seen over time. Adjusting the models for whether participants took antidepressant medication at baseline or had a family history of lung cancer had little impact on the findings. Models were robust to exclusion of observations with large residual values.
Discussion
Summary
This study demonstrates that a diagnosis of pulmonary nodules on a CT scan following an Early CDT®-Lung positive result for lung cancer screening does not result in an adverse psychological response in relation to affect, health anxiety, thought intrusion and illness perception compared to those who had a normal CT scan in both the short and medium-term. Although those in the nodule group had statistically significantly fewer avoidance behaviours than those in the normal CT group at 3 months than at 6 months, the differences between the mean scores in the nodule and normal CT groups were small at both time points.
Strengths and limitations
To our knowledge, this is the first study examining the psychological impact of receiving a pulmonary nodule diagnosis following a novel antibody test and chest CT scan within a UK population. Strengths of our study include use of a range of psychological outcome measures, which included positive as well as negative psychological responses, measures were repeated at multiple time points, a very high follow-up rate and analyses were adjusted for baseline measures where possible. However, it is possible that there may be small but potentially clinically important differences, which we did not have sufficient power to detect. Although a lower p-value (0.01) was used for significance testing of changes in scores between groups over time, multiple significance testing may have resulted in significant findings for the IES avoidance score. However, even if our IES Avoidance score findings are not due to type 1 error, differences in mean scores between the nodule and normal CT group were small and unlikely to be clinically meaningful.(18) As we did not know whether participants had received their CT scan result at the time of completing the 1-month questionnaire, this study does not evaluate the immediate response to receiving a pulmonary nodule diagnosis.
Comparison with existing literature
Previous studies examining the psychological impact of a pulmonary nodule diagnosis have found contrasting results. (18, 19, 24, 35, 36) Two studies in America found that individuals diagnosed with pulmonary nodules reported emotional distress (measured using the IES) shortly after diagnosis (time not specified)(35) and up to 2 or more years after diagnosis (19, 36).These findings differ from our study and those of the NELSON trial, with the latter showing an early (2 months after diagnosis)(18) and temporary clinically important increase in IES scores in individuals with nodules.(19) Additionally, the NELSON trial did not find that health-related quality of life (HRQoL) was affected by a pulmonary nodule diagnosis (19), which contrasts with a study in France. (24) This found a significantly lower HRQoL at 6-months post-diagnosis in those with pulmonary nodules compared to the French general population. (24) There are multiple factors that could explain the differences seen between these studies and ours. These include differences in screening procedures (our study used the Early CDT®-Lung test to identify those for CT scanning whereas other studies used CT screening alone or included participants found to have pulmonary nodules during routine clinical care), study populations, timing of questionnaire administration, definitions of pulmonary nodules, mode of nodule detection (screened versus incidentally detected), whether the study compared to a control group and whether adjustments were made for baseline measures. Additionally, our study participants received information explaining pulmonary nodules prior to their radiological investigations and enclosed with their CT scan results.
It is not possible to directly equate the findings of this study with those of the UKLS, which did not compare individuals with pulmonary nodules to those with a normal CT. (15, 17) Participants with pulmonary nodules will have been included in the UKLS "repeat scan required group" for the 2-week outcomes analysis and in the "false positive" group for the up to 2-years outcome analysis. A statistically significant, but not clinically important, increase in lung cancer worry was found at 2 weeks in those needing repeat scans compared to those with a negative CT scan result. No other statistically significant or clinically important differences were found in lung cancer worry, anxiety or depression at 2 weeks or up to 2 years, which is consistent with our findings.
There are several potential explanations for our finding that participants in the nodule group had a more positive psychological response (lower avoidance scores) than the normal CT group. It is possible that receiving a positive Early CDT®-Lung test psychologically prepared participants to receive an abnormal CT scan result, leading to a more positive psychological response than in studies where the CT scan is the first abnormal result a participant receives. Furthermore, receiving a diagnosis of pulmonary nodules after a positive Early CDT®-Lung test may have provided participants with reassurance, as this may be perceived as an "explanation" for the positive Early CDT®-Lung test, whilst those with a normal CT scan may have interpreted this as contradictory to the blood test finding, and experienced a lack of reassurance. It is also possible that participants with a positive Early CDT®-Lung test were preparing themselves psychologically to receive a CT result suspicious for lung cancer, and a diagnosis of pulmonary nodules may have been perceived as a much more favourable outcome, with a more positive psychological response. The manner in which the CT results were communicated may also have been important in determining the psychological response. Those with pulmonary nodules were sent their results by letter. This said the scan was satisfactory but had shown small nodules within one of the lungs which were less than 8mm in size and were most likely to be of little health concern. The letter also offered the option to discuss their scan results face-to-face with a doctor from the study team. In addition, participants were advised that the nodules would be monitored with further CT scans and any changes in nodules would result in a face-to-face discussion with a doctor.
There was a also a small but statistically significant difference in positive affect scores at baseline, with the nodule group having a higher score than those with a normal CT. Higher positive affect scores have been associated with a lower incidence of psychological illness,(37) so this may also potentially explain our finding of lower avoidance scores in those with nodules than in those with a normal CT at 3 months.
Implications for research and practice
Our findings provide some reassurance to clinicians concerned about the potential harms of lung cancer screening using a novel blood antibody test followed by serial CT scanning, should it be more widely implemented. There is likely to be little impact on health services in terms of emotionally distressed patients seeking help after pulmonary nodules being found on screening CT scans. Further work is required to explore the short-term impact (i.e. within a month) of a diagnosis of pulmonary nodules in the context of a screening programme and patients' understanding of the results of both blood tests and CT scans, and the impact of their understanding on psychological responses.
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The University of Dundee received funding from the Scottish Executive, the University of Glasgow Table 2 . Demographic characteristics at baseline amongst participants in the nodule group and those in the normal CT group (% indicates column percentage unless otherwise stated). Table 3 . Psychological measures at baseline amongst participants in the nodule group and those in the normal CT group (% indicates column percentage unless otherwise stated). Table 4 . Psychological measures at 1, 3 and 6 months amongst participants in the nodule group and those in the normal CT group (% indicates column percentage unless otherwise stated). Table 5 . Difference between means and odds ratios for psychological measures at 1, 3 and 6 months comparing participants in the nodule group to those in the normal CT group. χ²(1) = 1.63, p = 0.20
Age at leaving full-time education (yearsmedian (IQR))
[2] 16 (15, 16) [7] 16 (15, 16) z = 0.29, p = 0.77 
Work Status
Statistical Test Positive and Negative Affect Schedule (PANAS)
Positive affect score (median (IQR*)) (mean (SD**)) Negative affect score (median (IQR)) (mean (SD)) [3] 37.4 (27, 41.6) 34. 5 χ²(1) = 0.01 p = 0.91 χ²(1) = 0.001 p = 0.98 χ²(1) = 0.12 p = 0.73 χ²(1) = 0.24 p = 0.63 χ²(1) = 0.79 p = 0.37 χ²(1) = 0.22 p = 0.64 χ²(1) = 0.09 p = 0.77
Lung Cancer Risk Perception
What are the chances that you will develop lung cancer over the next [0] 6 (4, 11) 8.0 (5.3) [0] 5 (3, 9) 7.0 (5.8) [0] 6 (3, 12) 7.8 (5.5) Impact of Events Scale Intrusion score Median (IQR) (mean (SD)) Avoidance score Median (IQR) (mean (SD)) [1] 0.5 (0, 6) 4.2 (6.9)
[1] 0.5 (0, 5) 4.7 (8.2) [0] 2 (0, 7) 4.7 (6.6) [0] 2 (0, 10) 6.4 (8.8) [0] 0 (0, 6) 4.1 (6.8) [0] 0 (0, 13) 6.8 (10.7)
[1] 0 (0, 6) 3.8 (6.4) [3] 1 (0, 8. give a score of 0-20*. Cronbach's alpha =0.82. Impact of events scale (IES) 1) Intrusion score 2) Avoidance score

Adapted from the original scale used for bereaved individuals by changing the referent event to "being tested for lung cancer". Fifteen questions covered intrusive thoughts and avoidant behaviour following lung cancer screening, with 4point Likert scale (0-3) responses to give an avoidance score ranging from 0-24* and an intrusion score ranging from 0-21*. Cronbach's alpha for the original scale =0.78 for the intrusion score and 0.82 for the avoidance score. Based on the revised illness perception questionnaire, assessing emotional response generated by illness. Seven questions, each selected as the item with the highest factor loading in each subscale in a study of ovarian cancer screening, with 5-point Likert scale (1-5) responses. Answers were dichotomised to "agree" vs. "disagree". "Neutral" responses were categorised as "disagree." Cronbach's alpha for the subscales ranges from 0.79-0.89. Lung cancer risk perception 1) Absolute risk (What are the chances that you will develop lung cancer over the next 5 years?) 2) Relative risk (Compared to other people of your age and sex, how likely are you to develop lung cancer over the next 5 years?)   Assessed awareness of risk of developing lung cancer. Absolute risk responses ranged from 1 in 1000 to ≥ 1 in 10 (don't know option included), dichotomised to "low risk" (1 in 1000 to 1 in 250 and don't know) vs. "high risk" (1 in 100 to 1 in 10). Relative risk was assessed using 6 possible responses (don't know option included) ranging from a lot less likely to much more likely, dichotomised to "less likely" vs. "more likely." Don't know responses were categorised as "less likely."
Moss
Questions developed for the ECLS study.
*Higher score indicates a greater degree of the psychological outcome.
Highlights
Pulmonary nodules are commonly found on CT scans screening for lung cancer (LC)
Some non-UK studies show negative psychological impacts of pulmonary nodule diagnosis
We explored psychological impacts of nodule diagnosis during LC screening in the UK There was little impact on affect, health anxiety, worry, illness perception or risk perception There were fewer short-term avoidance symptoms in those diagnosed with nodules
